跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
POMALIDOMIDA ERAWYA 4 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
POMALIDOMIDA ERAWYA 4 MG CAPSULAS DURAS EFG
Approved
STANDARD
POMALIDOMIDA ERAWYA 4 MG CAPSULAS DURAS EFG
Laboratorios Basi Industria Farmaceutica S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 22, 2025
Approval ID
94336a41f2449e99
Company
Laboratorios Basi Industria Farmaceutica S.A.
Type
Standard
Approval Details
Approval Id
94336a41f2449e99
Drug Cima Aemps Name
POMALIDOMIDA ERAWYA 4 MG CAPSULAS DURAS EFG
Register Number
90058
Holder Company Name
Laboratorios Basi Industria Farmaceutica S.A.
Marketing Company Name
Laphysan S.A.U.
Authorization Date
2025-01-22
Dosage Form
CÁPSULA DURA
Dose
4 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Laboratorios Basi Industria Farmaceutica S.A.
Active Ingredients
POMALIDOMIDA
4 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 22, 2025
Approval ID
94336a41f2449e99
Type
Standard
Back to CIMA-AEMPS Approvals
